查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1579984

心臟組織工程市場：按材料類型、技術、組件、最終用戶、應用分類 - 全球預測 2025-2030

Cardiac Tissue Engineering Market by Material Type, Technology, Component, End User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心臟組織工程市場價值為96.8億美元，預計到2024年將達到104.5億美元，複合年成長率為8.52%，到2030年將達到171.6億美元。

心臟組織工程涉及創建生物人工組織來修復或取代受損的心臟組織，代表著治療心血管疾病的突破，而心血管疾病是全球死亡的主要原因。該領域結合了生物醫學工程、材料科學和細胞生物學的原理，透過組織重塑和再生來解決心臟衰竭和心肌梗塞問題。這項技術的需求源於當前心臟病治療的重大限制，包括捐贈器官的短缺和與移植相關的併發症。其應用範圍從藥物測試的實驗室模型到治療性植入和再生療法。最終用途範圍主要包括研究機構、生物製藥公司和醫療保健產業。影響市場成長的主要因素包括增加研發投資、提高細胞相容性的生物材料的進步以及心血管疾病盛行率的上升。商機在於3D生物列印和創新支架材料開發等技術突破。為了利用這些優勢，相關人員可以專注於與大學和研究中心的合作，以促進創新和長期成長。然而，高昂的研究成本、臨床應用的挑戰以及嚴格的監管途徑等限制因素帶來了巨大的挑戰。圍繞幹細胞的使用以及將技術融入傳統醫療實踐的倫理擔憂也阻礙了市場的成長。儘管如此，該領域的創新時機已經成熟，特別是奈米功能化生物材料的開發和改進的細胞採購技術。為了實現業務成長，投資擴充性的製造流程和個人化醫療方法可以產生高回報。對這個市場的洞察表明，這是一個充滿活力且不斷發展的市場，在技術進步和不斷成長的醫療保健需求的推動下具有巨大的成長潛力。

主要市場統計
基準年[2023] 96.8億美元
預測年份 [2024] 104.5億美元
預測年份 [2030] 171.6億美元
複合年成長率（%） 8.52%

市場動態：揭示快速發展的心臟組織工程市場的關鍵市場洞察

供需的動態交互作用正在改變心臟組織工程市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球心血管疾病盛行率不斷上升
    • 提高臨床醫生和患者對組織工程在心臟病治療中的益處和潛力的認知和接受度
  • 市場限制因素
    • 與創建功能組織相關的技術挑戰和複雜性
  • 市場機會
    • 增加對再生醫學領域的資金和投資，以支持研究和開發活動。
    • 生物技術公司、學術機構和研究機構之間的策略合作和夥伴關係，以推動創新
  • 市場挑戰
    • 嚴格的監管環境和長期的臨床試驗

波特的五力：駕馭心臟組織工程市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心臟組織工程市場的外部影響

外部宏觀環境因素在塑造心臟組織工程市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解心臟組織工程市場的競爭格局

對心臟組織工程市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣心臟組織工程市場供應商績效評估

FPNV定位矩陣是評估心臟組織工程市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃心臟組織工程市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對心臟組織工程市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球心血管疾病盛行率增加
      • 提高臨床醫生和患者對組織工程治療心臟病的益處和潛力的認知和接受度
    • 抑制因素
      • 創建職能組織涉及的技術挑戰和複雜性
    • 機會
      • 增加資金和投資，支持再生醫學領域的研發活動
      • 生物技術公司、學術機構和研究機構之間的策略合作和夥伴關係，以推動創新
    • 任務
      • 嚴格的監管環境和長期的臨床試驗
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依材料類型分類的心臟組織工程市場

  • 未來的材料
    • 先進生醫材料
    • 奈米複合材料
  • 混合材料
    • 生物合成混合物
  • 天然聚合物
    • 幾丁聚醣
    • 膠原蛋白
    • 纖維蛋白
    • 明膠
  • 合成聚合物
    • 聚己內酯
    • 聚乙二醇
    • Polyglycolic
    • 聚乳酸

第7章心臟組織工程市場：依技術分類

  • 3D生物列印
    • 噴墨生物列印
    • 雷射輔助生物列印
    • 微擠壓生物列印
  • 心臟組織工程模型
    • 體外模型
    • 生物模型
  • 細胞培養技術
    • QR 圖文化
    • 3D文化
    • 類器官培養

第8章心臟組織工程市場：依組成部分

  • 細胞培養套件和培養基
  • 細胞支架
  • 生長因子

第9章心臟組織工程市場：依最終使用者分類

  • 學術研究所
    • 研究醫院
    • 大學實驗室
  • 生技公司
    • 心臟設備製造商
    • 組織工程Start-Ups

第10章心臟組織工程市場：依應用分類

  • 臨床應用
    • 心臟再生
    • 心臟修復
    • 閥門工程
  • 藥品應用
    • 藥物發現
    • 個人化醫療
  • 調查申請
    • 疾病建模
    • 毒性評估

第11章美洲心臟組織工程市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區心臟組織工程市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲心臟組織工程市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Cellino Biotech 的 NEBULA計劃已從 ARPA-H 獲得 2500 萬美元的資金，以徹底改變再生醫學。
    • ATCC 和 Tissue Dynamics 的先進人工智慧驅動心臟類器官模型旨在徹底改變藥物開發
    • FluidForm Bio 透過創新的 FRESH 3D 生物列印推進心臟組織工程
  • 戰略分析和建議
    • 雅培實驗室

公司名單

  • Abbott Laboratories
  • Atrivion, Inc.
  • Auto Tissue Berlin GmbH
  • Avery Therapeutics, Inc.
  • Axol Bioscience Ltd.
  • Baxter International Inc.
  • BioCardia, Inc.
  • Cytograft Tissue Engineering, Inc.
  • Fujifilm Holdings Corporation
  • Heartseed Inc.
  • Humacyte, Inc.
  • Medtronic plc
  • Merck KGaA
  • Meril Lifesciences Pvt. Ltd.
  • Nanofiber Solutions
  • Organovo Holdings, Inc.
  • Regenovo Biotechnology Co., Ltd.
  • REPROCELL Inc.
  • Teijin Limited
  • Terumo Corporation
  • TissUse GmbH
  • Valo Health, Inc.
Product Code: MRR-DE0D254C1B76

The Cardiac Tissue Engineering Market was valued at USD 9.68 billion in 2023, expected to reach USD 10.45 billion in 2024, and is projected to grow at a CAGR of 8.52%, to USD 17.16 billion by 2030.

Cardiac Tissue Engineering involves creating bioartificial tissues to repair or replace damaged heart tissues, presenting a revolutionary advancement for treating cardiovascular diseases, the leading cause of death globally. This field merges principles from biomedical engineering, material science, and cell biology to enable tissue reconstruction and regeneration, hence addressing heart failure or myocardial infarction. The necessity of this technology arises from the significant limitations of current heart disease treatments, such as donor organ scarcity and transplantation-related complications. Its applications range from laboratory models for drug testing to therapeutic implants and regenerative therapies. The end-use scope primarily includes research institutions, biopharmaceutical companies, and healthcare sectors. Key factors influencing market growth include increased investment in R&D, advances in biomaterials that enhance cell compatibility, and rising prevalence of cardiovascular disorders. Opportunities lie within technological breakthroughs like 3D bioprinting and the development of innovative scaffolding materials. To leverage these, stakeholders can focus on partnerships with universities and research centers to foster innovation and long-term growth. However, limitations such as the high cost of research and clinical translation challenges, along with stringent regulatory pathways, present formidable challenges. Market growth is also hindered by ethical concerns over stem cell use and technology integration into traditional medical practices. Still, the sector remains ripe for innovation, particularly in the development of nano-functionalized biomaterials and improved cell sourcing techniques. For business growth, investing in scalable manufacturing processes and personalized medicine approaches could yield high returns. Insight into this market reveals it as dynamic yet nascent, with significant potential growth driven by technological advancements and increasing healthcare demands, requiring strategic navigation of regulatory, ethical, and technical challenges to realize its full potential.

KEY MARKET STATISTICS
Base Year [2023] USD 9.68 billion
Estimated Year [2024] USD 10.45 billion
Forecast Year [2030] USD 17.16 billion
CAGR (%) 8.52%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Tissue Engineering Market

The Cardiac Tissue Engineering Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of cardiovascular diseases globally
    • Increasing awareness and acceptance among clinicians and patients about the benefits and potential of tissue engineering in treating heart disease
  • Market Restraints
    • Technical challenges and complexities associated with creation of functional tissues
  • Market Opportunities
    • Increased funding and investment in the field of regenerative medicine to support research and development activities
    • Strategic collaboration and partnerships among biotech companies, academic institutions, and research organizations to drive innovation
  • Market Challenges
    • Stringent regulatory landscape and prolonged clinical trials

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Tissue Engineering Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Tissue Engineering Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Tissue Engineering Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Tissue Engineering Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Tissue Engineering Market

A detailed market share analysis in the Cardiac Tissue Engineering Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Tissue Engineering Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Tissue Engineering Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Tissue Engineering Market

A strategic analysis of the Cardiac Tissue Engineering Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Tissue Engineering Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Atrivion, Inc., Auto Tissue Berlin GmbH, Avery Therapeutics, Inc., Axol Bioscience Ltd., Baxter International Inc., BioCardia, Inc., Cytograft Tissue Engineering, Inc., Fujifilm Holdings Corporation, Heartseed Inc., Humacyte, Inc., Medtronic plc, Merck KGaA, Meril Lifesciences Pvt. Ltd., Nanofiber Solutions, Organovo Holdings, Inc., Regenovo Biotechnology Co., Ltd., REPROCELL Inc., Teijin Limited, Terumo Corporation, TissUse GmbH, and Valo Health, Inc..

Market Segmentation & Coverage

This research report categorizes the Cardiac Tissue Engineering Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Material Type, market is studied across Future Materials, Hybrid Materials, Natural Polymers, and Synthetic Polymers. The Future Materials is further studied across Advanced Biomaterials and Nano-composite Materials. The Hybrid Materials is further studied across Bio-Synthetic Blends. The Natural Polymers is further studied across Chitosan, Collagen, Fibrin, and Gelatin. The Synthetic Polymers is further studied across Polycaprolactone, Polyethylene Glycol, Polyglycolic Acid, and Polylactic Acid.
  • Based on Technology, market is studied across 3D Bioprinting, Cardiac Tissue Engineering Models, and Cell Culture Techniques. The 3D Bioprinting is further studied across Inkjet Bioprinting, Laser-Assisted Bioprinting, and Microextrusion Bioprinting. The Cardiac Tissue Engineering Models is further studied across In Vitro Models and In Vivo Models. The Cell Culture Techniques is further studied across 2D Culture, 3D Culture, and Organoid Cultures.
  • Based on Component, market is studied across Cell Culture Kits & Media, Cell Scaffolds, and Growth Factors.
  • Based on End User, market is studied across Academic & Research Institutes and Biotechnology Companies. The Academic & Research Institutes is further studied across Research Hospitals and University Laboratories. The Biotechnology Companies is further studied across Cardiac Device Manufacturers and Tissue Engineering Startups.
  • Based on Application, market is studied across Clinical Applications, Pharmaceutical Applications, and Research Applications. The Clinical Applications is further studied across Heart Regeneration, Heart Repair, and Valve Engineering. The Pharmaceutical Applications is further studied across Drug Discovery and Personalized Medicine. The Research Applications is further studied across Disease Modelling and Toxicology Assessment.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cardiovascular diseases globally
      • 5.1.1.2. Increasing awareness and acceptance among clinicians and patients about the benefits and potential of tissue engineering in treating heart disease
    • 5.1.2. Restraints
      • 5.1.2.1. Technical challenges and complexities associated with creation of functional tissues
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased funding and investment in the field of regenerative medicine to support research and development activities
      • 5.1.3.2. Strategic collaboration and partnerships among biotech companies, academic institutions, and research organizations to drive innovation
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory landscape and prolonged clinical trials
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Tissue Engineering Market, by Material Type

  • 6.1. Introduction
  • 6.2. Future Materials
    • 6.2.1. Advanced Biomaterials
    • 6.2.2. Nano-composite Materials
  • 6.3. Hybrid Materials
    • 6.3.1. Bio-Synthetic Blends
  • 6.4. Natural Polymers
    • 6.4.1. Chitosan
    • 6.4.2. Collagen
    • 6.4.3. Fibrin
    • 6.4.4. Gelatin
  • 6.5. Synthetic Polymers
    • 6.5.1. Polycaprolactone
    • 6.5.2. Polyethylene Glycol
    • 6.5.3. Polyglycolic Acid
    • 6.5.4. Polylactic Acid

7. Cardiac Tissue Engineering Market, by Technology

  • 7.1. Introduction
  • 7.2. 3D Bioprinting
    • 7.2.1. Inkjet Bioprinting
    • 7.2.2. Laser-Assisted Bioprinting
    • 7.2.3. Microextrusion Bioprinting
  • 7.3. Cardiac Tissue Engineering Models
    • 7.3.1. In Vitro Models
    • 7.3.2. In Vivo Models
  • 7.4. Cell Culture Techniques
    • 7.4.1. 2D Culture
    • 7.4.2. 3D Culture
    • 7.4.3. Organoid Cultures

8. Cardiac Tissue Engineering Market, by Component

  • 8.1. Introduction
  • 8.2. Cell Culture Kits & Media
  • 8.3. Cell Scaffolds
  • 8.4. Growth Factors

9. Cardiac Tissue Engineering Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
    • 9.2.1. Research Hospitals
    • 9.2.2. University Laboratories
  • 9.3. Biotechnology Companies
    • 9.3.1. Cardiac Device Manufacturers
    • 9.3.2. Tissue Engineering Startups

10. Cardiac Tissue Engineering Market, by Application

  • 10.1. Introduction
  • 10.2. Clinical Applications
    • 10.2.1. Heart Regeneration
    • 10.2.2. Heart Repair
    • 10.2.3. Valve Engineering
  • 10.3. Pharmaceutical Applications
    • 10.3.1. Drug Discovery
    • 10.3.2. Personalized Medicine
  • 10.4. Research Applications
    • 10.4.1. Disease Modelling
    • 10.4.2. Toxicology Assessment

11. Americas Cardiac Tissue Engineering Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Cardiac Tissue Engineering Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Cardiac Tissue Engineering Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Cellino Biotech's NEBULA project secures USD 25 million funding from ARPA-H to revolutionize regenerative medicine
    • 14.3.2. Advanced AI-Driven cardiac organoid model by ATCC and Tissue Dynamics aims to revolutionize drug development
    • 14.3.3. FluidForm Bio advances cardiac tissue engineering with Innovative FRESH 3D Bioprinting
  • 14.4. Strategy Analysis & Recommendation
    • 14.4.1. Abbott Laboratories

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Atrivion, Inc.
  • 3. Auto Tissue Berlin GmbH
  • 4. Avery Therapeutics, Inc.
  • 5. Axol Bioscience Ltd.
  • 6. Baxter International Inc.
  • 7. BioCardia, Inc.
  • 8. Cytograft Tissue Engineering, Inc.
  • 9. Fujifilm Holdings Corporation
  • 10. Heartseed Inc.
  • 11. Humacyte, Inc.
  • 12. Medtronic plc
  • 13. Merck KGaA
  • 14. Meril Lifesciences Pvt. Ltd.
  • 15. Nanofiber Solutions
  • 16. Organovo Holdings, Inc.
  • 17. Regenovo Biotechnology Co., Ltd.
  • 18. REPROCELL Inc.
  • 19. Teijin Limited
  • 20. Terumo Corporation
  • 21. TissUse GmbH
  • 22. Valo Health, Inc.

LIST OF FIGURES

  • FIGURE 1. CARDIAC TISSUE ENGINEERING MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC TISSUE ENGINEERING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CARDIAC TISSUE ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CARDIAC TISSUE ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC TISSUE ENGINEERING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC TISSUE ENGINEERING MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ADVANCED BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NANO-COMPOSITE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIO-SYNTHETIC BLENDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FIBRIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY POLYETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INKJET BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY LASER-ASSISTED BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MICROEXTRUSION BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY IN VITRO MODELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY IN VIVO MODELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 2D CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ORGANOID CULTURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE KITS & MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC DEVICE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TISSUE ENGINEERING STARTUPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART REGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VALVE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DISEASE MODELLING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TOXICOLOGY ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 82. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 84. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 85. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 86. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 90. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 91. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 92. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 94. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 95. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 96. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 99. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 100. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 102. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 103. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 104. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 106. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 107. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 108. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 109. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 111. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 112. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 113. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 114. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 116. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 117. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 119. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 120. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 121. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 123. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 124. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 125. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 126. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 128. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 129. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 130. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 131. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 133. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 134. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 136. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 137. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 138. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 140. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 141. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 142. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 143. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 145. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 146. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 147. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 148. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 150. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 151. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 153. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 154. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 155. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 157. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 158. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 159. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 160. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 162. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 163. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 164. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 165. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 167. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 168. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 170. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 171. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 172. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 191. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 193. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 194. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 195. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 196. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 198. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 199. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 200. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 201. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 203. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 204. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 206. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 207. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 208. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 210. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 211. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 212. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 213. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 215. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 216. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 217. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 218. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 220. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 221. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 223. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 224. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 225. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 227. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 228. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 229. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 230. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 232. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 233. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 234. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 235. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 237. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 238. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 240. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 241. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 242. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 244. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 245. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 246. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 247. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 249. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 250. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 251. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 252. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 254. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 255. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 257. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 258. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 259. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 261. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 262. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 263. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 264. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 265. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 266. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 267. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 268. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 269. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 271. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 272. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 274. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 275. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 276. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 278. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 279. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 280. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 281. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 283. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 284. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 285. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 286. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 288. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 289. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 291. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 292. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 293. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 295. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 296. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 297. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 298. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 299. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 300. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 301. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 302. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 303. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 304. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 305. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 306. PHILIPPINES CARDIAC TISSUE ENGINEERI